Sydney: Australia para COVID-19 kelaff te local vaccine bonai thaka toh roki jaishe, keli koile trials para HIV bemari thikaishe. Government khan para etu nemite vaccine toh besari ase koishe. University of Queensland (UQ) aro biotech firm CSL, para bona vaccine te Antibodies ola te ekta candidates logot kolti HIV positive test results paishe,etu 4 candidates pithor te ase koikena bona manuh khan para janai thishe. Hoilebi, vaccine toh “healthy” aro SARS-COV-2 virus logot immune response toh Phase 1 trial te 216 participants logot eku serious nai koishe.
CSL aro Australian government melikena Phase 2 and Phase 3 trials toh rokai thishe. “etu fesla loboli toh besi dukh ase, vaccine toh jolti para laki ase aro etu sob manuh laga sobse tangor kam ase”, koikena UQ professor Paul Young para khobor toh janaishe. “CSL para UQ vaccine toh 51 million doses bonaboli contract loikena thaka toh ulta Oxford vaccine Britain laga AstraZeneca vaccine toh extra 20 million doses bonabo, sob melaikena 53 million neshina bonaboli koishe.
Add Comment